Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM107 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARHGDIB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506100 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
GBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALNT10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRR34-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOXA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OGFOD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GCHFR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP1M1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFI30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YBEY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRNDE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBMS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CKLF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR2G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on